Curriculum Vitae

PERSONAL DETAILS
ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Head of Department, UNIVERSITI MALAYA, 01/10/2020 to present
  • Head of Department, UNIVERSITI MALAYA, 01/10/2018 to 30/09/2020
  • Head of Department, UNIVERSITI MALAYA, 01/08/2014 to 31/07/2016
  • Head of Department, UNIVERSITI MALAYA, 01/07/2014 to 31/07/2014
  • Head of Department, UNIVERSITI MALAYA, 01/09/2012 to 30/06/2014
  • Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya, 08/08/2011 to 15/08/2014
  • Ahli Majlis Penasihat Perubatan, Pusat Perubatan Universti Malaya, University Malaya, 30/07/2011 to 30/06/2014
  • Chairman for Exam Question Vetting Committee (Dept of Psychological Medicine), Faculty, 09/07/2011 to 30/06/2014
  • Ahli Jawatankuasa Etika Perubatan, Pusat Perubatan Universiti Malaya, University Malaya, 09/07/2011 to 09/10/2014
  • Penyelaras Program Sarjana Perubatan Psikologi, Faculty, 09/07/2011 to 30/06/2014
  • Ahli Jawatankuasa Ubat-ubatan dan Therapeutik, Pusat Perubatan Universiti Malaya, University Malaya, 09/07/2011 to 30/06/2014
  • Penyelaras Unit Kajian Psikopharmakologi, Jabatan Perubatan Psikologi, Faculty, 01/06/2001 to 30/06/2014
  • Head of Department, UNIVERSITI MALAYA, 01/07/2012 to 31/08/2012
  • Head of Department, UNIVERSITI MALAYA, 09/07/2011 to 30/06/2012
  • Pengerusi, Jawatankuasa Latihan Bersama Ijazah Sarjana Psikiatri, National, 10/07/2011 to 31/12/2012
  • Internal Examiner for Post Graduate Exam, Master in Psychological Medicine, National, 03/12/2007 to present
  • Internal Examiner for MBBS Final Exam, Faculty, 01/06/2001 to present
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • PHD(2007) (UM), PSYCHOPHARMACOLOGY, UNIVERSITI MALAYA (UM)
  • MPM(2001) (UM), PERUBATAN PSIKOLOGI(PSYCHIATRY AND PSYCHOPHARMACOLOGY), UNIVERSITI MALAYA (UM)
  • MBBS(UM)(1995), MEDICINE, UNIVERSITI MALAYA (UM)
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • Pacific Rim College of Psychiatrists, Board of Directors, 2021 to present (International)
  • National Conjoint Board for Postgraduate Psychiatry Training, President/ Chief, 2021 to 2022 (National)
  • Asian College of Neuropsychopharmacology, Board of Directors, 2021 to present (International)
  • Malaysian Psychiatric Association, President/ Chief, 2020 to present (National)
SPECIALIZATION
(Area)
Area of Expertise
  • PSYCHIATRY (Psychopharmacology)
    • Research Interest
  • Bipolar Disorder
  • Depression
  • Psychopharmacology
  • Schizophrenia
    • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • MGC - Master In Psychological Medicine, Post Graduate, UNIVERSITY MALAYA (2008/2009 - 1 2 )
  • MBBS - Phase 3B Psychiatry Posting, First Degree, UNIVERSITY MALAYA (2009/2010 - 1 2 )
  • MBBS - Phase 3B Psychiatry Posting, First Degree, UNIVERSITY MALAYA (2008/2009 - 1 2 )
  • MGC - Master In Psychological Medicine, Post Graduate, UNIVERSITY MALAYA (2009/2010 - 1 2 )
  • MBBS - Phase 3B Psychiatry Posting, First Degree, UNIVERSITY MALAYA (2010/2011 - 1 2 )
  • MGC - Master in Psychological Medicine, Post Graduate, UNIVERSITY MALAYA (2010/2011 - 1 2 )
  • MBBS - Phase 3B Psychiatry Posting, First Degree, UNIVERSITY MALAYA (2011/2012 - 1 2 )
  • MGC - Master in Psychological Medicine, Post Graduate, UNIVERSITY MALAYA (2011/2012 - 1 2 )
    • PUBLICATIONS
    (Title of publication in APA style)
    WoS
    2021
    • Nair, N., Ng, C. G., & Sulaiman, A. H. (2021). Depressive symptoms in residents of a tertiary training hospital in Malaysia: The prevalence and associated factors. Asian Journal of Psychiatry, 56, 7. doi: 10.1016/j.ajp.2021.102548
    Scopus
    2022
    • Abousheishaa A.A., Sulaiman A.H., Huri H.Z., Kamis S.F.B., Hamidi H., Ang W.C., Zainal Z.A.B., Shamsuddin N., Guan N.C. (2022). Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study, BMC health services research. 22(1), 321. doi:10.1186/s12913-022-07681-4
    • Narendra Kumar M.K., Francis B., Hashim A.H., Zainal N.Z., Abdul Rashid R., Ng C.G., Danaee M., Hussain N., Sulaiman A.H. (2022). Prevalence of Anxiety and Depression among Psychiatric Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective, Healthcare (Switzerland). 10(3), . doi:10.3390/healthcare10030532
    • Jeon H.J., Ju P.C., Sulaiman A.H., Aziz S.A., Paik J.W., Tan W., Bai D., Li C.T. (2022). Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression an Asian Sub-group Analysis from the SUSTAIN-2 Study, Clinical Psychopharmacology and Neuroscience. 20(1), 70-86. doi:10.9758/cpn.2022.20.1.70
    Refereed Journals
    2021
    • Chow, SK; Francis, B; Ng, YH; Naim, N; Beh, HC; Ariffin, MAA; Yusuf, MHM; Lee, JW; Sulaiman, AH 2021. Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective. HEALTHCARE (WoS)
    • Nair, N; Ng, CG; Sulaiman, AH 2021. Depressive symptoms in residents of a tertiary training hospital in Malaysia: The prevalence and associated factors. ASIAN JOURNAL OF PSYCHIATRY (WoS)
    • Soon Ken Chow, Benedict Francis, Yit Han Ng, Najmi Naim, Hooi Chin Beh, Mohammad Aizuddin Azizah Ariffin, Mohd Hafyzuddin Md Yusuf, Jia Wen Lee, Ahmad Hatim Sulaiman. Religious Coping, Depression and Anxiety among Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective. Healthcare 2021 Jan 15;9(1):79. doi: 10.3390/healthcare9010079. (WoS)
    • Syahrir Zaini, Ahmad Hatim Sulaiman, Hasniza Zaman Huri, Koh Ong Hui, Jesjeet Singh Gill, Benedict Francis, Tan Chok How, Fatin Liyana Azhar, Ong Jen Yeung, Lim Kuok Quan, Nathratul Ayeshah Zulkifli, Navin Nair, Ng Chong Guan. Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana 50(1)(2021): 161-170.http://dx.doi.org/10.17576/jsm-2021-5001-16 (WoS)
    • Nair, N; Ng, CG; Sulaiman, AH 2021. Depressive symptoms in residents of a tertiary training hospital in Malaysia: The prevalence and associated factors. ASIAN JOURNAL OF PSYCHIATRY.10.1016/J.AJP.2021.102548 (WoS)
    2020
    • Sulaiman, AH; Sabki, ZA; Jaafa, MJ; Francis, B; Razali, KA; Rizal, AJ; Mokhtar, NH; Juhari, JA; Zainal, S; Ng, CG 2020. Development of a Remote Psychological First Aid Protocol for Healthcare Workers Following the COVID-19 Pandemic in a University Teaching Hospital, Malaysia. HEALTHCARE (WoS)
    • Kaur, K; Sulaiman, AH; Yoon, CK; Hashim, AH; Kaur, M; Hui, KO; Sabki, ZA; Francis, B; Singh, S; Gill, JS 2020. Elucidating Mental Health Disorders among Rohingya Refugees: A Malaysian Perspective. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (WoS)
    • Sulaiman, A.H, Zuraida A.S, Jaafa M.J., Francis B., Razali K.A., Aliaa J.R., Mokhtar N.H, Juhari J.A, Zainal S., and Chong G.N. (2020) .Development of a Remote Psychological First Aid Protocol for Healthcare Workers Following the COVID-19 Pandemic in a University Teaching Hospital, Malaysia. Healthcare, 8(3), 228. (WoS)
    • Oon-Arom, A; Likhitsathian, S; Maneeton, B; Sulaiman, AH; Shih-Yen, EC; Udomratn, P; Chen, CH; Srisurapanont, M 2020. Subjective depressive symptoms associated with pain in patients with major depressive disorder: Findings from the study on the aspect of Asian depression. PERSPECTIVES IN PSYCHIATRIC CARE.  (Tier 3, Impact Factor = 1.24) (WoS)
    • Damodaran, I.; Hui, K.O.; Nordin, A.S.A.; Yee, A.; Gill, J.S.; Francis, B.; Azhar, F.L.; Sulaiman, A.H. An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. Healthcare 2020, 8, 533. (WoS)
    • Nakao Iwata, Jun Ishigooka, Won-Hyoung Kim, Bo-Hyun Yoon, Shih-Ku Lin, Ahmad Hatim Sulaiman, Rowena Cosca, Lina Wang, Yury Suchkov, Alexey Agarkov, Kei Watabe, Tomohito Matsui,Takayuki Sato, Yoshifumi Inoue, Teruhiko Higuchi, Christoph U. Correll, John M. Kan.(2020). Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study. Schizophrenia Research 215(2020):408 - 415 (WoS)
    • Iwata, N; Ishigooka, J; Kim, WH; Yoon, BH; Lin, SK; Sulaiman, AH; Cosca, R; Wang, L; Suchkov, Y; Agarkov, A; Watabe, K; Matsui, T; Sato, T; Inoue, Y; Higuchi, T; Correll, CU; Kane, JM 2020. Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study. SCHIZOPHRENIA RESEARCH (WoS)
    • Damodaran, I; Hui, KO; Nordin, ASA; Yee, A; Gill, JS; Francis, B; Azhar, FL; Sulaiman, AH 2020. An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. HEALTHCARE (WoS)
    • Aya Ahmed Abousheishaa, Ahmad Hatim Sulaiman, Hasniza Zaman Huri, Syahrir Zaini, Nurul Adha Othman, Zulhilmi Aladdin, Ng Chong Guan. Global Scope of Hospital Pharmacy Practice: A Scoping Review. Healthcare 2020, 8, 143; doi:10.3390/healthcare8020143 (WoS)
    • Ewa Wajs, Leah Aluisio, Richard Holder, Ella J. Daly, Rosanne Lane, Pilar Lim, Joyce E. George, Randall L. Morrison, Gerard Sanacora, Allan H. Young, Siegfried Kasper, Ahmad Hatim Sulaiman, Cheng-Ta Li, Jong-Woo Paik, Husseini Manji, David Hough, Jennifer Grunfeld, Hong Jin Jeon, Samuel T. Wilkinson, Wayne C. Drevets, and Jaskaran B. Singh. Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2). J Clin Psychiatry 81:3, Jun 2020 (WoS)
    • Ahmad Hatim Sulaiman, Zuraida Ahmad Sabki , Mohd Johari Jaafa , Benedict Francis , Khairul Arif Razali , Aliaa Juares Rizal , Nor Hazwani Mokhtar , Johan Arif Juhari , Suhaila Zainal , Chong Guan N. Online Based Psychological First Aid Model Following COVID-19: A Stepwise Approach to Psychological Recovery Among Health Care Workers in a Teaching Hospital, Malaysia. Healthcare 2020, 8, 228; doi:10.3390/healthcare8030228 (WoS)
    2019
    • Benedict Francis,Jesjeet Singh Gill , Ng Yit Han, Chiara Francine Petrus ,Fatin Liyana Azhar , Zuraida Ahmad Sabki ,Mas Ayu Said, Koh Ong Hui ,Ng Chong Guan and Ahmad Hatim Sulaiman. Religious Coping, Religiosity, Depression and Anxiety among Medical Students in a Multi-Religious Setting. Int. J. Environ. Res. Public Health 2019, 16(259); doi:10.3390/ijerph16020259 (WoS)
    • Zuraida, A.S., Che Zarrina, S., Sharifah Basirah, S.M., Goh, L.K., Sulaiman, A.H., Koenig, H.G. (2019). Islamic Integrated Cognitive Behavior Therapy: A Shari'ah-Compliant Intervention for Muslims with Depression. Malaysian Journal of Psychiatry. 28 (1). (SCOPUS)
    • Rusdi Abd Rashid, Sharmilla Kanagasundram, Mahmoud Danaee, Hazreen Abdul Majid , Ahmad Hatim Sulaiman, Muhammad Muhsin Ahmad Zahari, Chong Guan Ng, Benedict Franci , Wan Azlinda IrneeWan Husin and Tin Tin Su. The Prevalence of Smoking, Determinants and Chance of Psychological Problems among Smokers in an Urban Community Housing Project in Malaysia .Int. J. Environ. Res. Public Health 2019, 16, 1762; doi:10.3390/ijerph16101762 (WoS)
    • Michael Bauera,Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos, Raffaella Ardau, Yavuz Ayhan, Christopher Baethge, Rita Bauer, Bernhard T. Baune, Claudia Becerra-Palars, Frank Bellivier, Robert H. Belmaker, Michael Berk, Yuly Bersudsky, ule Bicakci, Harriet Birabwa-Oketcho, Thomas D. Bjella, Jorge Cabrera, Eric Y. Wo Cheung,Maria Del Zompo, Seetal Dodd, Markus Donix, Bruno Etain, Andrea Fagiolini, Kostas N. Fountoulakis, Mark A. Frye, Ana Gonzalez-Pinto, John F. Gottlieb, Paul Grof, Hirohiko Harima, Chantal Henry, Erkki T. Isomets , Sven Janno, Fl vio Kapczinski, Mathias Kardell, Slim Khaldi, Sebastian Kliwicki, Barbara K nig, Timur L. Kot, Rikke Krogh, Mauricio Kunz, Beny Lafer, Mikael Land n, Erik R. Larsen, Ute Lewitzk, Rasmus W. Lichtao, Carlos Lopez-Jaramillo, Glenda MacQueen,Mirko Manchia, Wendy Marsh, M nica Martinez-Cengotitabengo, Ingrid Melle, F tima Meza-Urz , Mok Yee Ming, Scott Monteith, Gunnar Gorken, Enrica Mosc, Anton A. Mozzhegorov, Rodrigo Munoz, Starlin V. Mythria, Fethi Nacef,Ravi K. Nadella, Fabiano G. Nery, Ren E. Nielsen, Claire O'Donovan, Adel Omrania,Yamima Osher, Helle stermark S rensen, Uta Oualia, Yolanda Pica Ruiza, Maximilian Pilhatsch, Marco Pinna, Francisco D.R. da Ponte, Danilo Quiroza,Raj Ramesara, Natalie Rasgona, M.S. Reddy, Andreas Reifa, Philipp Ritter, Janusz K. Rybakowski, Kemal Sagduyu, Bharathram Sathur Raghuraman, ngela M. Scippa, Emanuel Severus, Christian Simhandl, Paul W. Stackhouse Jr.,Dan J. Stein, Sergio Strejilevich, Mythily Subramaniam, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagat, Yoshitaka Tatebayashi, Leonardo Tondo,Carla Torrent, Arne E. Vaaler, Edgar Vares, Julia Veeh, Eduard Vieta,Biju Viswanath, Maria Yoldi-Negrete, Mark Zetin, Yosra Zgueb, Peter C. Whybrow. Association between solar insolation and a history of suicide attempts in bipolar I disorder. Journal of Psychiatric Research 113 (2019) 1 9 (WoS)
    • Yan Sun, Gang Chen, Li Wang, Nan Li, Manit Srisurapanont, Jin Pyo Hong, Ahmad Hatim, Chia-hui Chen, Pichet Udomratn, Jae Nam Bae , Yi-Ru Fang, Hong Choon Chua, Shen-Ing Liu, Tom George, Dianne Bautista, Edwin Chan, A. John Rush, Hong Yang, Yun-Ai Su and Tian-Mei Si, on behalf of the Mood Disorders Research: Asian & Australian Network Perception of Stigma and Its Associated Factors Among Patients with Major Depressive Disorder: A Multicenter Survey from an Asian Population. Frontiers in Psychiatry: May 2019 | Volume 10 | Article 321 (WoS)
    2018
    • Ramli Musa and Ahmad Hatim Sulaiman. The Therapeutic and Psychosocial Interaction in Enhancing Drug Targets. Current Drug Target (2018) 19(12): 1351 (WoS)
    • Ahmad Hatim Sulaiman, Ramli Musa. Editorial: Advances in Psychopharmacological Treatment. Current Drug Target (2018).19(8): 855 (WoS)
    • Gill JS, Sulaiman AH. QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report. Turk Psikiyatri Derg. 2018 ;29(1):67-68. (WoS)
    • Syahrir Zaini , Harvin Anbu Manivanna Bharathy , Ahmad Hatim Sulaiman , Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan. Development of a Strategic Tool for Shared Decision-Making in the Use of Antidepressants among Patients with Major Depressive Disorder: A Focus Group Study. Int. J. Environ. Res. Public Health 2018, 15, 1402; doi:10.3390/ijerph15071402 (WoS)
    • Anne Yee, Huai Seng Loh , Teng Aik Ong, Chong Guan Ng,Ahmad Hatim Sulaiman. Randomized, Double-Blind, Parallel- Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men. American Journal of Men s Health. DOI: 10.1177/1557988318784152. journals.sagepub.com/home/jmh (WoS)
    • Anne Yee, Huai Seng Loh, Mahmoud Danaee, Shahrzad Riahi, Chong Guan Ng, and Ahmad Hatim Sulaiman. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment. Journal of Sexual Medicine 2018. https://doi.org/10.1016/j.jsxm.2017.12.004 (WoS)
    • Syahrir Zaini, NG Chong Guan , Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Hasniza Zaman Huri, Siti Hadijah Shamsudin. The Use of Antidepressants for Physical and Psychological Symptoms in Cancer. Current Drug Target 2018 Feb 26. doi: 10.2174/1389450119666180226125026. [Epub ahead of print] (WoS)
    • Emsley R, Ahokas A, Suarez A, Marinescu D, D ci I, Lehtmets A, Milanova V, Lee MS, Didi R, Araszkiewicz A, Sulaiman AH, Blanchot FP, Crutel VS, Antoine C, Penelaud PF. Efficacy of Tianeptine 25-50 mg in Elderly Patients With Recurrent Major Depressive Disorder: An 8-Week Placebo- and Escitalopram-Controlled Study. (WoS)
    2017
    • Ng Chong Guan, PhD1, Salina Mohamed, MPM2, Kiran Kaur MD 3 Ahmad Hatim Sulaiman, PhD1, Nor Zuraida Zainal, MPhil1, Nur Aishah Taib, MD3 , MyBCC Study group. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One.12(3):e0172975. doi: 10.1371/journal.pone.0172975. (WoS)
    • Joni Bing Fei Teoh, Anne Yee, Mahmoud Danaee, Chong Guan Ng, Ahmad Hatim Sulaiman. Erectile Dysfunction Among Patients on Methadone Maintenance Therapy and Its Association With Quality of Life. Journal of Addiction Medicine 2017. 11: 40-46. (WoS)
    • Narong Maneeton, Sirijit Suttajit, Benchalak Maneeton, Surinporn Likhitsathian , Kanokkwan Eurviyanukul, Pichet Udomratn, Edwin Shih-Yen Chan, Tian-Mei Si, Ahmad Hatim Sulaiman, Chia-Hui Chen, Dianne Bautista, Manit Srisurapanont. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder. Nordic Journal of Psychiatry July 2017. DOI: 10.1080/08039488.2017.1335344 (WoS)
    • Tahereh Seghatoleslam, Hussain Habil, Ahmad Hatim, Abolfazl Ardakani, Khafidz Ishak, Rusdi Rashid. Evaluation of Psychometric Properties of the Second Version of the Taqwa (Piety) Questionnaire in Bahasa Melayu. J Relig Health. DOI 10.1007/s10943-017-0362-8 (WoS)
    • Guan Chong Ng, Salina Mohamed, Ahmad Hatim Sulaiman, Nor Zuraida Zainal. Anxiety and Depression in Cancer Patients: The Association with Religiosity and Religious Coping. J Relig Health (2017) 56:575-590. (WoS)
    2016
    • Tak Lam Lo, Matthew Warden, Yanling He, Tianmei Si, Seshadri Kalyanasundaram, Manickam Thirunavukarasu, Nurmiati Amir, Ahmad Hatim, Tomas Bautista, Cheng Lee, Robin Emsley, Jose Olivares, Yen Kuang Yang, Ronnachai Kongsakon, David Castle. Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region. Asia-Pacific Psychiatry.2016 (WoS)
    • Anne Yee, Mahmoud Danaee, Huai Seng Loh, Ahmad Hatim Sulaiman, Chong Guan Ng. Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment.PLoS One.Jan 2016. DOI:10.1371/journal.pone.0147852 (WoS)
    • Ng CG, Lai KT, Tan SB, Sulaiman AH, Zainal NZ. (2016) The Effect of Five Minutes Mindful Breathing to the Perception of Distress and Physiological Responses in Palliative Care Cancer Patients: A Randomized Controlled Study. Journal of Palliative Medicine. 19(9): 917-924 (WoS)
    • Rita Bauer, J rn Conell, Tasha Glenn, Martin Alda, Raffaella Ardau, Bernhard T. Baune, Michael Berk, Yuly Bersudsky, Amy Bilderbeck, Alberto Bocchetta, Letizia Bossini, Angela M. Paredes Castro, Eric YW. Cheung,Caterina Chillotti, Sabine Choppin, Maria Del Zompo, Rodrigo Dias, Seetal Dodd, Anne Duffy, Bruno Etain, Andrea Fagiolini, Miryam Fern ndez Hernandez, Julie Garnham, John Geddes, Jonas Gildebro, Ana Gonzalez-Pinto, Guy M. Goodwin, Paul Grof, Hirohiko Harima, Stefanie Hassel, Chantal Henry, Diego Hidalgo-Mazzei, Vaisnvy Kapur, Girish Kunigiri, Beny Lafer, Erik R. Larsen, Ute Lewitzka, Rasmus W. Licht, Anne Hvenegaard Lund, Blazej Misiak, Scott Monteith, Rodrigo Munoz, Takako Nakanotani, Ren E Nielsen, Claire O Donovan, Yasushi Okamura, Yamima Osher, Patryk Piotrowski, Andreas Reif, Philipp Ritter, Janusz K. Rybakowski, Kemal Sagduyu, Brett Sawchuk, Elon Schwartz, ngela M. Scippa, Claire Slaney, Ahmad H. Sulaiman, Kirsi Suominen, Aleksandra Suwalska, Peter Tamar, Yoshitaka Tatebayashi, Leonardo Tondo, Eduard Vieta, Maj Vinberg, Biju Viswanath, Julia Volkert, Mark Zetin, Peter C. Whybrowax, Michael Bauer. (2016) Internet use by patients with bipolar disorder: Results from an international multi-site survey. Psychiatry Research, 242:388-394. (WoS)
    • Chong Guan Ng, Kiah Tian Lai, Seng Beng Tan, Ahmad Hatim Sulaiman, Nor Zuraida Zainal (2016). The Effect of 5 Minutes of Mindful Breathing to the Perception of Distress and Physiological Responses in Palliative Care Cancer Patients: A Randomized Controlled Study. Journal of Palliative Medicine. DOI: 10.1089/jpm.2016.0046 (WoS)
    • NA Hashim, S Ariaratnam, MR Salleh, MA Said, AH Sulaiman. Depression and associated factors in Patients with Type 2 Diabetes Mellitus. East Asian Archives of Psychiatry. 26(2):77-82 (Non-WoS/Non-SCOPUS)
    2015
    • Chong Guan Ng, Salina Mohamed, Mee Hoong See, Faizah Harun, Maznah Dahlui, Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Nur Aishah Taib. Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: a 1-year prospective study. Health and Quality of Life Outcomes 12/2015; 13(1):205. DOI:10.1186/s12955-015-0401-7. (WoS)
    • Michael Bauer, Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos , Raffaella Ardau, Christopher Baethge, Rita Bauer, Frank Bellivier, Robert H Belmaker, Michael Berk, Thomas D Bjella, Letizia Bossini, Yuly Bersudsky, Eric Yat Wo Cheung, J rn Conell, Maria Del Zompo, Seetal Dodd, Bruno Etain, Andrea Fagiolini, Mark A. Frye, Kostas N Fountoulakis, Jade Garneau-Fournier, Ana Gonzalez- Pinto, John F. Gottlieb, Hirohiko Harima, Stefanie Hassel, Chantal Henry, Apostolos Iacovides, Erkki T Isomets Fl o Kapczinski, Sebastian Kliwicki, Barbara K nig, Rikke Krogh, Mauricio Kunz, Beny Lafer, Erik R Larsen, Ute Lewitzka, Carlos Lopez- Jaramillo, Glenda MacQueen, Mirko Manchia, Wendy Marsh, M nica Martinez-Cengotitabengoa, Ingrid Melle, Scott Monteith, Gunnar Morken, Rodrigo Munoz , Fabiano G Nery, Claire O'Donovan, Yamima Osher, Andrea Pfennig, Danilo Quiroz, Raj Ramesar, Natalie Rasgon, Andreas Reif, Philipp Ritter, Janusz K Rybakowski, Kemal Sagduyu, gela M Scippa, Emanuel Severus, Christian Simhandl, Dan Stein, Sergio Strejilevich, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagata, Yoshitaka Tatebayashi, Carla Torrent, Eduard Vieta, Biju Viswanath, Mihir J Wanchoo, Mark Zetin, Peter C Whybrow. Influence of light exposure during early life on the age of onset of bipolar disorder. Journal of Psychiatric Research.Volume: 64 Pages: 1-8. May 2015 (WoS)
    • Srisurapanont M, Likhitsathian S, Chua HC, Udomratn P, Chang S, Maneeton N, Maneeton B, Chen CH, Chan ESY, Bautista D, Sulaiman AHB. Clinical and sociodemographic correlates of severe insomnia in psychotropic drug- free, Asian outpatients with major depressive disorder.Journal of Affective Disorders. Volume: 186 Pages: 26-31. Nov 2015. (WoS)
    • Park S, Sulaiman AH, Srisurapanont M, Chang SM, Liu CY, Bautista D, Ge L, Chua HC, Hong, JP The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder.Psychiatry Research Volume: 228 Issue: 3 Pages: 277-282. Aug 2015. (WoS)
    • Yee A, Chin SC, Hashim AHB,Singh MKAPH, Loh HS, Sulaiman AH, Ng CG. Anhedonia in depressed patients on treatment with selective serotonin reuptake inhibitor anti-depressant - A two-centered study in Malaysia. International Journal of Psychiatry in Clinical Practice. Volume: 19 Issue: 3 Pages: 182-187 (WoS)
    • M. Bauer, T. Glenn, M. Alda, O.A. Andreassen, E. Angelopoulos, R. Ardau, C. Baethge, R. Bauer, F. Bellivier, R.H. Belmaker, M. Berk, T.D. Bjella, L. Bossini, Y. Bersudsky, E.Y.W. Cheung, J. Conell, M. Del Zompo, S. Dodd, B. Etain, A. Fagiolini, M.A. Frye, K.N. Fountoulakis, J. Garneau-Fournier, A. Gonzalez-Pinto, H. Harima, S. Hassel, C. Henry, A. Iacovides, E.T. Isomets F. Kapczinski, S. Kliwicki, B. K nig, R. Krogh, M. Kunz, B. Lafer, E.R. Larsen, U. Lewitzka, C. Lopez-Jaramillo, G. MacQueen, M. Manchia, W. Marsh, M. Martinez- Cengotitabengoa, I. Melle, S. Monteith, G. Morken, R. Munoz, F.G. Nery, C. O Donovan, Y. Osher, A. Pfennig, D. Quiroz, R. Ramesar, N. Rasgon, A. Reif, P. Ritter, J.K. Rybakowski, K. Sagduyu, A.M. Scippa, E. Severus, C. Simhandl, D.J. Stein, S. Strejilevich, A. Hatim Sulaiman, K. Suominen, H. Tagata, Y. Tatebayashi, C. Torrent, E. Vieta, B. Viswanath, M.J. Wanchoo, M. Zetin, P.C. Whybrow. 2015. Influence of birth cohort on age of onset cluster analysis in Bipolar I Disorder. European Psychiatry 30(1): 99-105 (WoS)
    • Liu YH, Chen L, Su YA, Fang YR, Srisurapanont M, Hong JP, Hatim A, Chua HC, Bautista D, Si TM. Is Early-onset in Major Depression a Predictor of Specific Clinical Features with More Impaired Social Function?. Chin Med J 2015;128:811-5. (WoS)
    • Chong Guan Ng, Salina Mohamed, Mee Hoong See, Faizah Harun, Maznah Dahlui, Ahmad Hatim Sulaiman,Nor Zuraida Zainal, Nur Aishah Taib and on behalf of the MyBCC Study group. 2015. Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: A 1-year prospective study. Health and Quality of Life Outcomes 13(1): 205 (Open Access) (WoS)
    • Anxiety, depression, perceived social support and quality of life in Malaysian breast cancer patients: a 1-year prospective study. Chong Guan Ng1*, Salina Mohamed2, Mee Hoong See3, Faizah Harun3, Maznah Dahlui4, Ahmad Hatim Sulaiman1, Nor Zuraida Zainal1, Nur Aishah Taib3 and on behalf of the MyBCC Study group (WoS)
    2014
    • Ahmad Hatim Sulaiman, Mas Ayu, Mohd Hussain Habil, Rusdi Rashid, Amer Siddiq, Ng Chong Guan, Marhani Midin, Nik Ruzyanei Nik Jaafar, Hatta Sidi, Srijit Das.The Risk and Associated Factors of Methamphetamine Psychosis in Methamphetamine Dependent Patients in Malaysia. Comprehensive Psychiatry. 55 (Jan 2014):S89- S94. (Tier 2; Impact Factor = 2.2) (WoS)
    • Sim MS, Hatim A, Diong SH, Mohamed Z. Genetic polymorphism in DTNBP1 gene is associated with methamphetamine-induced panic disorder. J Addict Med. 2014 Nov-Dec;8(6):431-7 (WoS)
    • Siti Norsyuhada Roffeei, Zahurin Mohamed, Gavin P Reynolds, Mas Ayu Said, Ahmad Hatim, Elsa Haniffah Mejia Mohamed, Syarinaz Ahmad Aida, Nor Zuraida Zainal. Association of FTO, LEPR and MTHFR gene polymorohisms with metabolic syndrome in schizophrenia patients receiving antispychotics. Pharmacogenomics (2014). 15 (4): 477-485. (WoS)
    • Ah-Young Lim, Ah-Rong Lee, Ahmad Hatim, Si Tian-Mei, Chia-Yih Liu, Hong Jin Jeon, Pichet Udomratn, Dianne Bautista, Edwin Chan, Shen-ing Liu, Hong Choon Chua, Jin Pyo Hong. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries. BMC Psychiatry 2014, 14:37 (WoS)
    • Siti Norsyuhada Roffeei, Gavin P. Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida & Zahurin Mohamed. 2014. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Hum. Psychopharmacol Clin Exp 29: 38 45 (WoS)
    • Michael Bauer, Tasha Glenn, Martin Alda, Ole A. Andreassen, Elias Angelopoulos,Raffaella Ardau, Christopher Baethge, Rita Bauer, Frank Bellivier,Robert H. Belmaker, Michael Berk, Thomas D. Bjella, Letizia Bossini,Yuly Bersudsky, Eric Yat Wo Cheung, Jörn Conell, Maria Del Zompo, Seetal Doddk,Bruno Etain, Andrea Fagiolini, Mark A. Fryes, Kostas N. Fountoulakis ,Jade Garneau-Fournier, Ana Gonz lez-Pinto, Hirohiko Harima,Stefanie Hassel,Chantal Henry, Apostolos Iacovides, Erkki T. Isomets , Fl vio Kapczinski,Sebastian Kliwicki, Barbara K nig, Rikke Kroghad, Mauricio Kunz, Beny Lafer,Erik R. Larsen, Ute Lewitzk, Carlos Lopez-Jaramillo, Glenda MacQueen,Mirko Manchi, Wendy Marsh, M nica Martinez-Cengotitabengo, Ingrid Melle,Scott Monteith, Gunnar Morken, Rodrigo Munoz, Fabiano G. Nery,Claire O Donovan, Yamima Osher, Andrea Pfennig, Danilo Quiroz, Raj Ramesar,Natalie Rasgon, Andreas Reif, Philipp Ritter, Janusz K.Rybakowski,Kemal Sagduyu, ngela M. Scippaao, Emanuel Severus, Christian Simhandl,Dan J. Steinap, Sergio Strejilevich, Ahmad Hatim Sulaiman, Kirsi Suominen, Hiromi Tagata, Yoshitaka Tatebayashi, Carla Torrent, Eduard Vieta,Biju Viswanath, Mihir J. Wanchoo, Mark Zetin, Peter C. Whybrow. Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study. Journal of Affective Disorders. 167(2014):104 111 (WoS)
    • Ng, C. G., Boks, M. P. M., Roes, K. C. B., Zainal, N. Z., Sulaiman, A. H., Tan, S. B., & de Wit, N. J. Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four- week, randomized, double-blinded, placebo-controlled study. European Neuropsychopharmacology(0). doi: http://dx.doi.org/10.1016/j.euroneuro.2014.01.016 (WoS)
    • Schreiner A, Hargarter L, Hitschfield K, Lee JI, Lenskaya I, Sulaiman AH, Diels J. Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR). Current Medical Research and Opinion 30(7):1279-1289. (WoS)
    • Ng C.G., Mohamed S., Wern T.Y., Haris A., Zainal N.Z., Sulaiman A.H.2014. Comparison of Psychotropic Prescriptions between Oncology and Cardiology Inpatients: Result from a Pharmacy Database in a Teaching Hospital in Malaysia. Asian Pacific Journal of Cancer Prevention. 15(10):4261 (WoS)
    2013
    • Ahmad H. Sulaiman, Dianne Bautista, Chia-Yih Liu, Pichet Udomratn, Jae Nam Bae, Yiru Fang,Hong C. Chua,Shen-Ing Liu,Tom George, Edwin Chan, Si Tian-mei, Jin Pyo Hong, Manit Srisurapanont,A. John Rush,and the Mood Disorders Research: Asian & Australian Network. Differences in psychiatric symptoms among Asian patients with depression: A multi-country cross- sectional study. Psychiatry and Clinical Neurosciences. (WoS)
    • Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu Said, Nor Zuraida Zainal, Mohad Hussain Habil, Ng Chong Guan. Non-Psychotic Psychiatric Co-Morbidities in Patients with Methamphetamine Dependence in Malaysia. International Medical Journal.(Accepted for Publication) (WoS)
    • Ng Chong Guan, Marco PM Boks, Ahmad Hatim Sulaiman, Nor Zuraida Zaina, Niek J De Wit. (2013). Diagnostic Criteria for Major Depressive Disorder in Cancer Patients; a review. International Journal of Psychiatry in Medicine. 45(1): 73-82. (WoS)
    • Koh Ong Hui, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Subash Kumar Pillai,Stephen Thevanathan Jambunathan, Rusdi Abdul Rashid. A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia. Bulletin of Clinical Psychopharmacology. 2013;23(1):14-23 (WoS)
    • M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.PHARMACOGENOMICS 14(5):505-14 APRIL 2013. Impact Factor: 3.43 DOI: 10.2217/pgs.13.25 (WoS)
    • Manit Srisurapanont, Jin Pyo Hong, Si Tian-mei, Ahmad Hatim, Chia-Yih Liu, Pichet Udomratn, Jae Nam Bae, Yiru Fang, Hong Choon Chua, Shen-Ing Liu, Tom George11 MD, Dianne Bautista, Edwin Chan & A. John Rush; For the MD RAN. Clinical features of depression in Asia: Results of a large prospective, cross-sectional study. Asia-Pacific Psychiatry 2013, DOI:10.1111/appy.12104. (WoS)
    • Mohd Fadzli Mohamad Isa, Ng Chong Guan, Rusdi Abd Rashid, Mohd Hussain Habil, Hatta Sidi, Mas Ayu Said, Ahmad Hatim Sulaiman.2013. Sexual Behaviour among Male Methamphetamine and Heroin Dependents in Selected Areas in Malaysia. Sains Malaysiana, 42(12): 1819-1826 (WoS)
    • Mas Ayu Said, A Hatim, MH Habil, Wan Zafidah, Haslina MY, Badiah Y, Ramli MA, Ananjit S, Sapini Y, Mohd Shah, Badli Mahmud, Awang Bulgiba, Noran N Hairi. Metabolic syndrome and monotherapy antipsychotic treatment among schizophrenia patients in Malaysia. Preventive Medicine. 2013; 57 ; S50 - S53 (WoS)
    2012
    • Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. An insight on career satisfaction level, mental distress, and gender differences in working conditions among Japanese Obstetricians and Gynecologists. The Journal of Obstetrics and Gynaecology Research, 2012. doi:10.1111/j.1447-0756.2012.01966.x (Early online publication) (WoS)
    • Ahmad Hatim Sulaiman, Mas Ayu Said, Srijit Das. Substance use, sexual intercourse, and condom non-use among depressed adolescents and young adults: scientific views.Journal of Adolescent Health, 2012;50:654-655. (WoS)
    • Sulaiman AH, Gill JS, Said MA, Zainal NZ, Hussein HM, Guan NC.2012. A Randomized, Placebo- Controlled Trial of Aripiprazole For The Treatment Of Methamphetamine Dependence and Associated Psychosis. International Journal of Psychiatry in Clinical Practice, 2012;Early Online: 1-8. doi:10.3109/13651501.2012.667116. (WoS)
    • Coppola D, Liu Y, Gopal S, Remmerie B, Samtani MN, Hough DW, Nuamah I, Sulaiman A, Pandina G. 2012. A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia. BMC Psychiatry,2012 Mar 28;12(1):26. (Tier 2; Impact Factor = 2.5) (WoS)
    • Eduard Vietaa, Stuart Montgomery, Ahmad Hatim Sulaiman, Rodrigo Cordoba, Benedicte Huberlant, Lupe Martinez, Andreas Schreiner. 2012. A randomized,double- blind,placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable inpatients with bipolar I disorder. European Neuropsychopharmacology(2012 Nov) 22 (11), 825 835 (WoS)
    • Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Mas Ayu said, Mohamad Hussain habil, Nor Zuraida Zainal, Chong Guan Ng. 2012. An open label study of aripiprazole for methamphetamine induce psychosis. Bulletin of Clinical Psychopharmacology.2012;22(2):121-9 (WoS)
    • Mas Ayu Said, Ahmad Hatim Sulaiman, Mohd Hussain Habil, Srijit Das, Abdul Kadir Abu Bakar, Rosliwati Md. Yusoff, Loo Tsui Huei, Shamshunnisah Abu Bakar. Metabolic syndrome and cardiovascular risk among schizophrenia patients receiving antipsychotics in Malaysia. Singapore Medical Journal,2012;53(12):801-807 (WoS)
    2011
    • A. Hatim, S. Mas Ayu, H. Habil, M. Mustafa, J. Gill, R. Rusdi and A. Amer Siddiq. Psychiatric co-morbidity and suicidality among methamphetamine dependent patients who seek treatment in Malaysia. European Neuropsyhopharmacology, 2011,21(2): S161 (WoS)
    2010
    • Mas Ayu S, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, Sam IC. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. American Journal of Tropical Medicine and Hygiene 2010; 83(6):1245-1248. (WoS)
    • Maw Shin Sim,Zahurin Mohamed,Ahmad Hatim,Vijaya Lejchimi Rajagopal,Mohamad Hussain Habil.2010. Association of brain-derived neurotrophic factor (Val66Met)genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Research (1357):91-96 (WoS)
    • Rusdi Abd. Rashid, Noor Zurani Md Haris Robson, Ahmad Hatim Sulaiman, Rabaiah Salleh, Nor Zuraida Zainal, Mas Ayu Said, Mohammad Hussain Habil. Schizophrenia, Substance use and aggressions: What are the relationships? Online Journal ASEAN Journal of Psychiatry. Vol. 11(1): Jan-June 2010. (Non-WoS/Non-SCOPUS)
    • Noor Zurani Md Haris Robson, Stephen Jambunathan, Jesjeet S Gill, Ahmad Hatim Sulaiman, Mohammad Hussain Habil. Research, casuistry and psychiatry An Asian perspective. Asean Journal of Psychiatry, Vol.11(1): Jan June 2010: 2-5 (Non-WoS/Non-SCOPUS)
    2009
    • Q.Q. Ang, Y.K. Wing, Y. He, A.H. Sulaiman, N.Y. Chiu, Y.C Shen, C. Zhang, K.H. Lee, P. Singh, R.E. Granger,J. Raskin, M. Dossenbach. 2009. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.The International Journal of Clinical Practice 63 (7):1041-1049. (Tier 1; Impact Factor = 2.4) (WoS)
    • A Hatim, J Tan,Mas Ayu, H Habil. Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotics agents.Malaysian Journal of Psychiatry. 2.4.2009:1-13 (Non-WoS/Non-SCOPUS)
    • David M. Clarke, Ahmad Hatim, Brian Ho, Jiyang Pan, Chee Ng, Kang-Seob Oh, Wu Wenyuan, Mak Ki-Yan. Somatic Symptoms of Depression and Anxiety in the Western Pacific Region: Questions and Answers. CNS Spectr. 2009;14(4):1-8 (WoS)
    • Ahmad Hatim. Is the patient really the same after a major depressive episode? Medicographia. April 2009: Volume 31(2): 9 10 (Non-WoS/Non-SCOPUS)
    2008
    • Ahmad Hatim S. Amphetamine type stimulant psychosis: a rising problems in Malaysia. Malaysian Journal of Psychiatry. December 2008: 17(2): 3- 6 (Non-WoS/Non-SCOPUS)
    • A Hatim, JS Gill, TH Yen, M Ariff, OM Lemming, MZ Azhar. Escitalopram in the Treatment of Malaysian Patients with Obsessive-compulsive Disorder. Hong Kong Journal of Psychiatry. December 2008: Volume 18 (4): 152 157 (SCOPUS)
    • Sharmilla T, Ahmad Hatim S, Jambunathan ST. Prevalence of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine in UMMC Kuala Lumpur. Malaysian Journal of Psychiatry. December 2008: 17(2): 37 46 (Non-WoS/Non-SCOPUS)
    2007
    • Jesjeet Singh Gill, Ahmad Hatim Sulaiman, Mohd Hussain Habil. The first methadone programme in Malaysia:overcoming obstacles and achieving the impossible. Asean Journal of Psychiatry., December 2007: Volume 8, 64-70 (Non-WoS/Non-SCOPUS)
    • Zuraida NZ, Ahmad HS. Religiosity and suicide ideation in clinically depressed patients. The Malaysian Journal of Psychiatry, March 2007: 16: 12-15 (Non-WoS/Non-SCOPUS)
    2006
    • Hatim A, Habil H, Jesjeet SG, Low CC, Joseph J, Jambunathan ST, Zuraida NZ. Safety and efficacy of rapid dose administration of quetiapine in the treatment of bipolar mania. Human Psychopharmacology: Clinical and Experimental, July 2006: Volume 21, 313-318. (WoS)
    • Sharmilla K, Ahmad HS. A comparison of insight in schizophrenia, bipolar affective disorder with psychosis and major depression with psychosis. The Malaysian Journal of Psychiatry, March 2006: 14: 35-40 (Non-WoS/Non-SCOPUS)
    • Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (SCOPUS)
    • Hatim A, Yen TH. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone and olanzapine: a naturalistic study in UMMC. Journal of University Malaya Medical Centre. 2006:Volume 9 (1), 23-29 (Non-WoS/Non-SCOPUS)
    • Pillai SK, Ahmad HS, Jesjeet SG, Jambunathan ST. Psychiatric posting in final year medical students: do attitudes change? The Malaysian Journal of Psychiatry, September 2006: 15:26-31. (Non-WoS/Non-SCOPUS)
    2004
    • Hang TJ, Hatim A. Insight among patients with schizophrenia in Hospital Permai. The Malaysian Journal of Psychiatry, March 2004: 12: 32-37 (Non-WoS/Non-SCOPUS)
    2002
    • Hatim A, Zuraida A, Tan KS, Tan CT. Prevalence and Associations of Post Stroke Depression. Neurological Journal of South East Asia, December 2002: 7: 71-75. (WoS)
    • Mas A, Hatim A.Stigma in Mental Illness: Attitudes of Medical Students Towards Mental Illness, 2002, Med. J. Malaysia, Vol. 57, no. 4, pg. 427-438 (WoS/SCOPUS)
    2001
    • Hatim A, Hussain H. General Practitioners View About Treating Schizophrenic Patients in General Practice Settings. The Malaysian Journal of Psychiatry, March 2001: 9(1): 43-47. (Non-WoS/Non-SCOPUS)
    • Hatim A, Yen TH. The Efficacy and Outcome of Clozapine Usage in Treatment Resistant Schizophrenic Patient in University Malaya Medical Centre. The Malaysian Journal of Psychiatry, September 2001: 9(2): 6-9. (Non-WoS/Non-SCOPUS)
    Book
    2011
    • M.H.Habil, R.Abdul Rashid & S.A.Jazaeri.2011.Perspectives of Addiction Medicine in Malaysia.
    2006
    • Hussain Habil, Ahmad Hatim. Kemurungan: Punca dan rawatan. University Malaya Press. 2006 (Non-WoS/Non-SCOPUS)
    2005
    • National Methadone Maintenance Therapy Guideline. Ministry of Health Malaysia May 2005.
    Article in Proceedings
    2011
    • M. Said, A.H. Sulaiman, M.H. Habil. 2011. Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results. European Psychiatry. Volume 26, Suppl 1. page (WoS)
    • Sim, Maw Shin; Sulaiman, Ahmad Hatim; Jaafar, Ahmad Nur Fayyadh Ahmad; et al. 2011. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews Volume: 43 Pages: 69-70. (WoS)
    2010
    • Said, M. A.; Sulaiman, A. H.; Habil, M. H. Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results. European Psychiatry Volume: 25, page (WoS)
    • Thavichachart, N.; Conde, B.; Sobrevega, E.; et al. Efficacy and tolerability study of flexibly dosed paliperidone ER in ASEAN schizophrenia patient who previously unsuccessfully treated with other oral antipsychotics . International Journal of Neuropsychopharmacology Volume: 13 Pages: 243 (WoS)
    2009
    • Hatim A, Ayu M, Habil H. Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia. European Neuropsychopharmacology Volume: 19 Pages: S654-S655 (WoS)
    • Hatim A, Ayu M, Mustafa M, Habil H. Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results. The World Journal of Biological Psychiatry. 2009; 10 (supp 1): 403 (WoS)
    2008
    • A. Hatim, M Ayu, H Habil, JT Tan. Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents. International Journal of Neuropsychopharmacology Volume: 11 Pages: 158-159 (WoS)
    • 282-283Said, MA; Sulaiman, AH; Yen, T; et al. Subgroup analysis of Malaysian patients in a randomised, placebo-controlled relapse-prevention study with escitalopram in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology Volume: 11 Pages: 282-283 (WoS)
    2007
    • Ahmad Hatim. Psychiatric posting in final year medical students: do attitudes change? World Psychiatric Association Regional Meeting. Seoul, Korea. April 18 21, 2007. (Non-WoS/Non-SCOPUS)
    2005
    • Ahmad Hatim, Hussain Habil, Mas Ayu. The use of buprenorphine in the treatment of opiate dependence in Malaysia. XIII World Congress of Psychiatry. Cairo, Egypt. 10-15 September 2005 (Non-WoS/Non-SCOPUS)
    2004
    • Gill JS, Koh OH, Hatim A, Jambunathan ST. First episode psychosis: cultural differences in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):81 (WoS)
    • Said, MA; Sulaiman, AH; Gill, JS. 2004. Diabetes mellitus, obesity and lipid abnormalities in schizophrenic patients treated with atypical antipsychotics. International Journal of Neuropsychopharmacology Volume: 7 Pages: S255. (WoS)
    • Gill JS, Jambunathan ST, Low CC, Jacob J, Hatim A. Implementing an Early intervention programme that caters to the need of the multicultural population in Malaysia. Schizophrenia Research, September 2004:Vol 70 (Suplement 1):29 (WoS)
    2002
    • M Ayu, A Hatim, S Norriah. Risk Factors of Major Depression Among the Post Stroke Patients: A Hospital Based Case-Control Study At University Malaya Medical Centre. The 34th Asia Pacific Academic Consortium for Public Health Conference. Kuala Lumpur, Malaysia. 17- 20 July 2002: page 22 (Non-WoS/Non-SCOPUS)
    • A Hatim, A Mas. Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient. XII World Congress of Psychiatry. Yokohama, Japan. 24 29 August 2002: volume 2: 169 (Non-WoS/Non-SCOPUS)
    2001
    • A Hatim, N Zuraida, KS Tan, CT Tan. Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur. 4th Biennial Convention of The ASEAN Neurological Association. Kuala Lumpur, Malaysia. 22- 24 March 2001: page 94. (Non-WoS/Non-SCOPUS)
    • A Hatim, N Zuraida. Prevalence and Clinical Determinants of Post Stroke Depression.7th World Congress of Biological Psychiatry. Berlin, Germany. 1- 6 July 2001. (Non-WoS/Non-SCOPUS)
    Mass Media(Newspaper,Radio,TV,Popular Magazine)
    2011
    • TV9. Nasi Lemak Kopi O. Masalah penderaan kanak-kanak. 20th February 2011.
    2010
    • Ajar seks bermula di rumah. I Luv Islam. 22 Oktober 2010. mukasurat 10.
    • Kesedaran perlu ada untuk berubah. I Luv Islam. 31 Disember 2010. Mukasurat 8.
    • Kesan penagihan methamphetamine. China Press. 2010
    2009
    • TV3. Malaysia Hari Ini. Anger Management. 16th January 2009
    • Don t let anxiety ruin your life. New Straits Times. Life and Times; 20th January 2009: page 8-9.
    • Penagih dadah sintetik sering hilang pertimbangan. Berita Minggu. 6th September 2009. page 3.
    2007
    • RTM: TV2. Social Phobia. 17th July 2007
    • TV9. Rancangan Keluarga di 9: Penyakit Bipolar. 24th December 2007.
    2006
    • Nescafe Kickstart Dream Job . 22nd January 2006.
    • TV2 (National Television). Antisocial personality disorder. 16th March 2006
    • Gila Meroyan (Post-partum Psychosis). Berita Minggu. 7th May 2006
    • TV3 (Wanita Hari Ini). Kemurungan (Depression). 13th June 2006.
    2005
    • Mangsa Tsunami perlu diberikan sokongan moral. Ruangan Wawancara. Mingguan Malaysia. 2 Januari 2005, mukasurat 7
    • SAKA, sekadar gangguan mental. Berita Harian . 1 Mei 2005. page 22
    2004
    • New hope for addicts. New Straits Times. March 31, 2004: page 9
    • Treating addiction as a medical condition. Health Today Magazine. April 2004: page 39.
    • Rawatan selamat kikis ketagihan dadah. Berita Harian. April 8, 2004.
    • Rancangan: Cegah Dan Rawat. April 19, 2004
    • Unsur ganas galak tingkah laku agresif. Mingguan Malaysia. Mei 23, 2004
    • Hit by hysteria. Sunday Mail May 23, 2004
    • Mimpi ngeri misteri ganguan tidur. Ruangan Kesihatan, Mingguan Malaysia. 7 November 2004. Mukasurat 25.
    2003
    • Psychiatrist s sofa is not all that bad. The New Sunday Times. Jan 19, 2003: page F4
    • Masyarakat masih kurang kesedaran penyakit skizophrenia. Berita Harian. September 12, 2003: page C13.
    2002
    • Befriending the depressed. The New Sunday Times. June 16, 2002: page F4
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    International Funding
  • RGH-MD-25. A double-blind, placebo-controlled, randomized withdrawal, multicenter clinical trial evaluating the efficacy, safety, and tolerability of Cariprazine in a Dose-Reduction Paradigm in the prevention of relapse in Bipolar I Disorder patients whose current episode is manic or depressive, with or without mixed features, Principal Investigator(PI), 2020 - 2023 (International)
  • RGH-MD-24. A Double-Blind Placebo-Controlled, Randomized Withdrawal Multicenter Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients with Schizophrenia. , Principal Investigator(PI), 2020 - 2023 (International)
  • A Double-blind, Randomized, Active -controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation , Principal Investigator(PI), 2018 - 2023 (International)
  • An Open-Label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression., Principal Investigator(PI), 2016 - 2022 (International)
  • A 52-week, Open-label, Prospective, Multicenter, International Study of a Transistion to the Paliperidone Palmitate 3-month Formulation in Patients with Schizophenia Previously Stabilized on the Paliperidone Palmitate 1-month Formulation, Principal Investigator(PI), 2016 - 2022 (International)
  • A Long Term Study of SM-134963 in Patients with Bipolar I Disorder., Principal Investigator(PI), 2015 - 2017 (International)
  • A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of SM-13496 for Treatment of Bipolar I Depression, Principal Investigator(PI), 2015 - 2020 (International)
  • A Multicenter, Randomized, Double-blind Trial to Assess the Efficacy and Safety of ASC-01 in Patients with Major Depressive Disorder, Principal Investigator(PI), 2015 - 2017 (International)
  • A phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administered doses of BI409306 during a 12-week treatment period in patients with schizophrenia on stable antipsychotic treatment. , Principal Investigator(PI), 2015 - 2017 (International)
  • Confirmatory Study of DSP-5423P in Patients with Schizophrenia , Principal Investigator(PI), 2015 - 2022 (International)
    • Private Funding
  • A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to be at Imminent Risk for Suicide", Principal Investigator(PI), 2017 - 2022 (International)
  • An Open-label Long-Term Extension Safety Study of Intranasal Esketamine in Treatment-resistant Depression , Principal Investigator(PI), 2017 - 2023 (International)
    • ALKERMES, INC (United States of America)
  • A phase 3, multicentre, randomized, double blinf, placebo conttrolled study of the efficacy and safety of ALKS 9072 in subjects with acute exacerbation of schizophrenia, Principal Investigator(PI), 2012 - 2014 (International)
    • Janssen Cilag
  • Study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase -5 inibitor. , Principal Investigator(PI), 2011 - 2012 (International)
  • Risperidone and olanzapine in patient utilization in the University of Malaya Medical Centre, Kuala Lumpur, Principal Investigator(PI), 2005 - 2006 (National)
    • Geran Penyelidikan Universiti Malaya (UMRG)
  • Efficacy and safety of escitalopram in diabetic patients with major depression. , Principal Investigator(PI), 2011 - 2012 (National)
  • The association study of various genetic polymorphisms and drug addiction to stimulants in Malaysian populations , Principal Investigator(PI), 2009 - 2010 (National)
    • Otsuka Pharmaceutical Development (United States of America)
  • An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Patients with Schizophrenia , Principal Investigator(PI), 2011 - 2018 (International)
    • Pfizer Sdn Bhd
  • Randomized controlled trial of the safety and efficacy of aripiprazole versus ziprazidone in schizophrenic patients with metabolic syndrome and diabetes mellitus , Principal Investigator(PI), 2010 - 2012 (National)
    • Lundbeck (Denmark)
  • Recognising ethnic differences in depression - a multinational, observational study to detect potential differences in depression in various asian populations. , Principal Investigator(PI), 2009 - 2011 (International)
  • Randomised, double-blind, parallel-group, placebo- controlled, duloxetine referenced, dose-finding study of Lu AA24530 in Major Depressive Disorder. , Principal Investigator(PI), 2007 - 2009 (International)
  • Escitalopram in the treatment of Malaysian patients with obsessive compulsive disorder, Principal Investigator(PI), 2006 - 2007 (National)
    • Janssen Cilag (United States of America)
  • A one year prospective study of safety, tolerability and pharmacokinetics of the highest avaialable dose of paliperidone palmitate in patients with schizophrenia, Principal Investigator(PI), 2008 - 2010 (International)
    • Short Term Research Fund (Vote F)(PJP)
  • Seroprevalence survey of Chikungunya virus in Bagan Panchor Malaysia, Consultant, 2008 - 2009 (National)
  • Association between genetic polymorhism with drug addiction to stimulants , Principal Investigator(PI), 2007 - 2008 (National)
    • Janssen Cilag (Europe)
  • A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder , Principal Investigator(PI), 2008 - 2009 (International)
    • Janssen- Cilag
  • An open-label prospective trial to explore tolerability, safety and efficacy of flexible dosed paliperidone ER in subjects with schizophrenia, Principal Investigator(PI), 2008 - 2009 (International)
    • Peruntukan Jangkamasa Pendek
  • Depression in a Group of Post Myocardial Infarct Patient , Consultant, 2007 - 2009
    • Merck Sharp and Dohme (MSD) (USA)
  • A phase IIA, randomized, double blind, placebo controlled, 2 period, cross over clinical trail to study the safety and efficacy of MK 0557 for the treatment of cognitive impairment in patients with schizophrenia , Principal Investigator(PI), 2007 - 2009 (International)
    • Duopharma Pharmaceutical
  • Methadone treatment for herion dependence in Malaysia., Consultant, 2005 - 2006 (National)
    • Astra Zeneca Pharmaceutical
  • Safety and efficacy of rapid dose administration of quetiapine in bipolar mania, Principal Investigator(PI), 2005 - 2006 (National)
    • SUPERVISION
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Risk factors for depression after myocardial infarction, Dr Amer Siddiq Amer Nordin, University of Malaya (UM) (Post Graduate Student)
    • Marital Therapy Case Protocol, Dr. Parameswaran, University of Malaya (UM) (Post Graduate Student)
    • Prescribing pattern of antidepressant and antipsychotic, Dr. Chin Loi Fei, University of Malaya (UM) (Post Graduate Student)
    • Insight among patients with schizophrenia in Hospital Permai, Dr. Ting Joe Hang, University of Malaya (UM) (Post Graduate Student)
    • Sexual behaviour among amphetamine type stimulant users in Malaysian drug rehabilitation centre, Dr Mohd Fadzli Mohamad Isa, University of Malaya (UM) (Post Graduate Student)
    • Prevalence of depression and anxiety among heroin dependence, Dr Rusdi Abd Rashid, University of Malaya (UM) (Post Graduate Student)
    • Case Protocol of Panic Disorder with Agaraophobia, Dr Zuraida Ahmad Sabki, University of Malaya (UM) (Post Graduate Student)
    • Prevalence of depression among patients with ischaemic heart disease, Dr Mashitah, University of Malaya (UM) (Post Graduate Student)
    • Risk factors of relapse among heroin addicts, Dr Aminuddin, University of Malaya (UM) (Post Graduate Student)
    • Case Protocol for Psychotherapy, Dr Khoo Yee Laim, University of Malaya (UM) (Post Graduate Student)
    • Service utilization and costs associated with switching to risperidone from previous treatment with typical antipsychotic agent, Dr John Tan Jin Teong, University of Malaya (UM) (Post Graduate Student)
    • Psychiatric posting in final year medical students: do attitudes change?, Dr Subash Kumar Pillai, University of Malaya (UM) (Post Graduate Student)
    • Insight among patients with schizophrenia, bipolar and depression, Dr Sharmilla Kanagasundram, University of Malaya (UM) (Post Graduate Student)
    • Depression and quality of life in patients with type 2 diabetes mellitus, Dr Nurul Azreen bt Hashim, University of Malaya (UM) (Post Graduate Student)
    • Risk factor for post-stroke depression, Dr Mas Ayu Said, University of Malaya (UM) (Post Graduate Student)
    • Association between single nucleotide polymorphisms of various candidate genes with methamphetamine dependence in the Malaysian population, Sim Maw Shin, University of Malaya (UM) (Post Graduate Student)
    Ongoing
    • The safety and efficacy of escitalopram in the treatment of major depression among diabetis mellitus patients., Dr Aisah Abdul Rahim, University of Malaya (UM) (Post Graduate Student)
    • EFFICACY OF AN EDUCATIONAL MODULE IN ENHANCING AWARENESS AND KNOWLEDGE ON SUBSTANCE ABUSE AMONGST SECONDARY SCHOOL CHILDREN, Tan Huey Jing, University of Malaya (UM) (Post Graduate Student)
    • The level and associated factors of anhedonia in patients with depression at the outpatient clinic of UMMC, Dr Chin Soo Cheng, University of Malaya (UM) (Post Graduate Student)
    UG Student/Clinical Fellowship
    (Title of Thesis),(Academic Session)
    Completed
    • Attitudes of paramedic towards patients with mental illness / MBBS, 2002/2003
    • Prevalence of Anxiety and depression among medical students / MBBS, 2003/2004
    • Prevalence attitude and practice towards cigarette smoking among medical doctors in UMMC / MBBS, 2005/2006
    • Body image concern among female university students / MBBS, 2005/2006
    • Patterns of antipsychotic use among hospitalized schizophrenic patients in UMMC / Bachelor of Pharmacy, 2006/2007
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • Meet the Expert Session: 20th World Congress of Psychiatry 10 - 13 March 2021, 10/03/2021 to 13/03/2021
    • Key Note Speaker: Malaysian Conference of Psychological Medicine 2020, 12/12/2020 to 13/12/2020
    • Schizophrenia Global Virtual Advisory Board, 09/12/2020 to 09/12/2020
    • Kursus Bimbingan Program Sarjana Psikiatri 2012, 16/12/2012 to 18/12/2012
    • Ahli Jawatankuasa Penganjur bagi Persidangan "International Society of Addiction Medicine Conference 2013", 01/01/2012 to 30/06/2013
    • Presented Lecture during Bipolar Education Forum In Hong Kong, 28/10/2011 to 30/10/2011
    • Lecture during Taiping Mental Health Conference, 15/10/2011 to 16/10/2011
    • Public Lecture and Facilitator during Schizophrenia Relapse Prevention Forum, 07/10/2011 to 09/10/2011
    • Invited as Panel Speaker in Talk Show "Nasi Lemak Kopi O" TV9, 20/02/2011 to 20/02/2011
    • Lecture on "How to prepare FDA inspection", Fullerton Hotel, Singapore. 24 November 2009., 24/11/2009 to 24/11/2009
    • Lecture on Management of Schizophrenia. Hospital Alor Star. 28 October 2009, 28/10/2009 to 28/10/2009
    • Lecture on Management of Depression. Hospital Bahagia Ulu Kinta. 30 July 2009., 30/07/2009 to 30/07/2009
    • Workshop on Treatment Resistant Schizophrenia. Hospital Penang. 12 May 2008, 12/05/2008 to 12/05/2008
    • Organizing Commitee: CINP Regional Conference 1 - 5 March 2008, KL Convention Centre, 01/03/2008 to 05/03/2008
    • Public Lectures on Depression. Armada Hotel, Petaling Jaya. 15 July 2007, 15/07/2007 to 15/07/2007
    • Organizing Committee: 12th Malaysian Conference on Psychological Medicine, 24-26 Jun 2007. Park Royal Hotel Kuala Lumpur., 24/06/2007 to 27/06/2007
    • Lecture on Stress Management at International Islamic University Malaysia, 27/02/2007 to 27/02/2007
    • Train the Trainer Workshop for Bipolar Psychoeducation. Le Meridien hotel, Kuala Lumpur. 4 March 2006, 04/03/2006 to 04/03/2006
    • Functionality in Schizophrenia Workshop. Hilton Hotel, Petaling Jaya. 22 January 2006., 22/01/2006 to 22/01/2006
    • Schizoprenia Workshop for General Practitioners. 13 November 2005. Hilton Petaling Jaya, 13/11/2005 to 13/11/2005
    • Lectures on Stress Management for Telekom Staff, 28/09/2005 to 28/09/2005
    • Organizing Committee: 10th Malaysian Conference on Psychological Medicine 24-26 Jun 2004, JW Marriot Hotel, Kuala Lumpur., 24/06/2004 to 26/06/2004
    ACADEMIC/PROFESSIONAL SERVICES
    Evaluation Activity
    (Activity),(Duration),(Category)
  • Reviewer for Journal of Public Health Policy , 2018 to 2018 (Article in Journal)
  • International Journal of Environmental Research and Public Health , 2018 to 2018 (Article in Journal)
  • Lymphocytes subsets and their association with the severity of patients with major depressive disorder. External examiner for University Sains Malaysia , 2017 to 2017 (Thesis)
  • Externer Examiner for Final MBBS Professional Exam at University Teknologi Mara , 2017 to 2019 (Externer Examiner For Final Mbbs Professional Exam)
  • Externer Examiner for Final MBBS professional Exam at Islamic International University, Malaysia, 2013 to 2013 (Externer Examiner for Final MBBS professional Exam)
  • External Examiner for final professional exam MD, University Sains Malaysia, 2013 to 2013 (External Examiner for final professional exam MD)
  • A study of social support, adjustment and academic stress among first year students at Syiah Kuala University, 2013 to 2013 (Thesis)
    • Expert Linkages
    (Linkages Description),(Organisation),(Duration of Involvement),(Level)
  • Editorial Board Member, International Journal of Bipolar Disorders, 2018 (International)
  • Guest Editor for special issue entitled "Advances in Psychopharmacological Treatment" (BSP-CDT-2016-HT68) , Current Drug Treatment, 2016 (International)
  • Consultant and Lectures, Substance Abuse Research Centre, Jazan University, Saudi Arabia., 2013 (International)
    • Academic/Technical Contribution
    (Activity),(Organisation),(Duration),(Role)
  • Ahli Jawatankuasa Penilaian Teknikal Ubat-ubatan Psikiatri, University Malaya Medical Centre , 2013 - 2022 (Expert Advisor)
  • Ahli Majlis Unit Perundingan Universiti Malaya, University Malaya , 2012 - 2018 (Committee Member)
  • Asia Bapineuzumab Advisory Board, Pfizer, 2012 - 2012 (Expert Advisor)
  • Chairman for Specialty (Psychiatry) Sub Committee, National Specialist Register (Malaysia), 2012 - 2014 (Chairman)
  • Trainer for PANSS and CGI scales, Bracket Global USA, 2012 - 2012 (Consultant )
  • University Malaya Medical Centre Ethics Committee, University Malaya Medical Centre , 2012 - 2020 (Committee Member)
    • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • Best Lecturer Award for Post Graduate (Psychiatry), Faculty of Medicine, 2017 (EDUCATION)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2013 (CERTIFICATE)
    • Pengarang Buku Terlaris 2007, Penerbitan Universiti Malaya, 2008 (OTHERS)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2006 (CERTIFICATE)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2004 (CERTIFICATE)
    • Anugerah Khidmat Cemerlang, Universiti Malaya, 2004 (RESEARCH)
    • Best Research Paper Competition, Malaysian Psychiatric Association, 2004 (RESEARCH)
    • Best Psychiatrist Trainee Award, Malaysian Psychiatric Association, 2001 (RESEARCH)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Pfizer MDD Mind Advisory Panel, Pfizer Inc, 01/02/2021 to 01/02/2021 (International)
    • JOHNSON & JOHNSON SOUTHEAST ASIA MEDICAL AFFAIRS, JOHNSON & JOHNSON SOUTHEAST, 01/11/2020 to 01/11/2021 (International)
    • Global Advisory Board, H Lundbeck A/S, 01/11/2020 to 01/11/2022 (International)
    • Psychiatry Expert Meeting, A.Menarini, 01/08/2018 to 01/08/2018 (National)
    • Regional Neuroscience Advisory Board, Janssen Asia Pacific, 01/08/2018 to 01/08/2018 (International)
    • Psychiatry Steering Committee, Johnson & Johnson Sdn. Bhd, 01/08/2018 to 01/08/2018 (National)
    • Consultant to Substance Abuse and Research Centre, Substance Abuse and Research Centre, Jazan University, Saudi Arabia, 01/04/2012 to 01/04/2014 (International)
    • A multicenter, randomized, double-blind, placebo-controlled, parallel grou-comparison trial of aripiprazole in the treatment of patients with bipolar disorder experiencing a manic or mixed episode, Otsuka Pharmaceutical Japan, 01/04/2008 to 01/04/2011 (International)
    • A phase 3 randomized, placebo-controlled, clinikal trial to study the safety and efficacy of three doses of lurasidone hcl in acutely psychotic patients with schizophrenia., Danippon Sumitomo, 01/04/2008 to 01/04/2010 (International)
    • A single dose, open-label, randomized, parallel group safety to assess the pharmacokinetic, safety and tolerability of a paliperidone palmitate 3 monthly formulation., Janssen Cilag, 01/04/2008 to 01/04/2012 (International)
    • A prospective, observational study comparing the frequency of treatment-emergent sexual dysfunction over 8 weeks in patients with major depressive disorder treated with either duloxetine hydrochloride or a selective serotonin reuptake inhibitor antidepressant and evaluated for 6 months, Eli Lilly Sdn Bhd, 01/04/2009 to 01/04/2010 (National)
    • A 3-weeks, open label study to evaluate the efficacy in agitation and safety of quetiapine fumarate (seroquel xr) in the treatment of patients with acute schizophrenia., Astra Zeneca Pharmaceutical, 01/04/2009 to 01/04/2010 (National)
    • Safety, tolerability and treatment response of paliperidone palmitate in subjects with schizophrenia when switching from oral antipsychotics., Janssen Cilag, 01/04/2006 to 01/04/2008 (National)
    • Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILLAR), Janssen Cilag, 01/04/2008 to 01/04/2010 (National)
    • A prospective, randomized, active controlled, rater blinded study of the prevention of relapse comparing palmitate with oral risperidone in adults with recently diagnosed schizophrenia who are at high risk of relapse., Janssen Cilag, 01/04/2009 to 01/04/2010 (International)
    • A one year multi national, multi centre, randomized, double blind, parallel group, fixed dose, bifeprunox study combining a 12 week placebo., Lundbeck, 01/04/2008 to 01/04/2012 (International)
    • Efficacy and safety of 2mg/ day of M100907 on sleep maintenance insomnia with a sub study of the effect of M100907 on stable type ii diabetes mellitus : a one year, multi centre, randomized, double blind, placebo controlled study., Sanofi Aventis, 01/04/2007 to 01/04/2009 (International)
    • A double-blind, randomized, parallel-group, placebo controlled study of the safety, tolerability and efficacy following sequential dose regimens of Lu 31-130 in male schizophrenia., Lundbeck, 01/04/2007 to 01/04/2010 (International)
    • A six week, double blind, placebo-controlled phase iii trial evaluating the efficacy, safety and pharmacokinetics of flexible doses of oral ziprazidone in adolescent subject with schizophrenia., Pfizer, 01/04/2006 to 01/04/2010 (International)
    • A multi-national, multi-center, double-blind, placebo-controlled, parallel group, fixed dose efficacy and safety study of SR58611a 350 mg twice daily vs placebo in adult with major depression., Sanofi Aventis, 01/04/2007 to 01/04/2010 (International)
    • A randomized,double blind,placebo controlled,parallel group study to evaluate the efficacy and safety of flexible dose paliperidone ER in the treatment of subject with schizoaffective., Quintiles East Asia, 01/04/2007 to 01/04/2009 (International)
    • A randomized double-blind, placebo controlled, parallel-group dose response study to evaluate the efficacy and safety of 3 fixed doses of paliperidone palmitate in subjects with schizophrenia, Janssen Cilag, 01/04/2007 to 01/04/2009 (International)
    • Chairman, Data safety Monitoring Board, Mitshubishi Tanabe Pharma Corporation, 01/03/2012 to 01/03/2016 (International)
    • Scientific Coordinator, Institut De Recherches Internationales Servier, 01/04/2012 to 01/04/2014 (International)
    • Consultancy Services, H. Lundbeck A/S, 01/04/2012 to 01/04/2013 (International)
    • A randomized, double-blind, parallel-group, placebo-controlled, fixed-dose study comparing the efficacy and safety of 3 doses of lu aa21004 in acute major depression., Takeda, 01/03/2009 to 01/03/2013 (International)
    • A multicenter, active-controlled double-blind, parallel group comparison trial to investigate the efficacy and safety of aripiprazole intramuscular depot (opc-14597imd) compared with aripiprazole tablet in patients with schizophrenia), Otsuka Pharmaceutical Japan , 01/03/2011 to 01/03/2015 (International)
    • Advisory Board Member, Wyeth Pharmaceutical Inc, 01/04/2006 to 01/04/2008 (International)
    • Scientific National Coordinator , Institut De Recherches Internationales Servier (IRIS), 01/03/2006 to 01/03/2015 (International)
    • Coordinating Investigator, Lundbeck A/S, 01/04/2007 to 01/04/2010 (International)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    PLEANARY SPEAKER
  • Early detetction of depression in patients with diabetes mellitus, Diabetes Asia 2013 Conference, 24/10/2013 to 27/10/2013, National Diabetic Institute (International)
  • Managing Broad Symptoms of Major Depressive Disorder, 9th Perak Mental Health Convention, 09/10/2012 to 10/10/2012, Hospital Bahagia Ulu Kinta (National)
  • Unmet needs of Bipolar and Schizophrenia, Unveiling the untypical, 23/10/2011 to 23/10/2011, Lundbeck Malaysia (National)
  • Managing bipolar disorder from acute to maintenance: focusing on patient outcomes, Symposium: Galvanizing the exploration of mental health conundrums of the young, adults and the elderly, 14/10/2011 to 15/10/2011, Pertubuhan Pendidikkan Psikiatri Taiping (National)
  • Atypical antipsychotics in mood disorders, 13th Johor Mental Health Conference, 20/05/2011 to 21/05/2011, Hospital Permai Johor (National)
  • Addiction Psychiatry, 12th Johor Mental Health Convention, 31/05/2010 to 02/06/2010, Hospital Permai Johor Bharu (National)
    • INVITED SPEAKER
  • Rating Rules for Hamilton Anxiety Scale , Asian Investigators Meeting, 15/11/2012 to 16/11/2012, Servier Pharmaceutical and Quintiles East Asia (International)
  • PANSS National Language Trainer, COMPASS Schizophrenia Investigators Meeting, 20/10/2012, Otsuka Pharmaceutical and Bracket Global (International)
  • Administering and rating the MADRS, Investigators Meeting for Study 13926A , 27/07/2012 to 29/07/2012, Lundbeck (International)
  • How to improve adherence in Bipolar Affective Disorder? Problems and Solutions in Asian Countries, The Bipolar Education Training in Asia Forum 2011, 28/10/2011 to 29/10/2011, Society for Advancement of Bipolar Affective Disorder (International)
  • Recognizing and managing depression in primary care, 4th Perak Health Conference 2011, 16/05/2011 to 18/05/2011, Malaysian Association of Public Health Physicians and Perak State Health Department (National)
  • The scourge about designer drugs, 6th National Conference on Addiction Medicine, 23/10/2010 to 25/10/2010, Addiction Medicine Association of Malaysia (National)
  • Metabolic syndrome in schizophrenia, 8th Perak Mental Health Convention, 08/10/2010 to 10/10/2010, Hospital Bahagia Ulu Kinta (National)
  • Wellness program, 7th Kuala Lumpur Mental Health Conference , 26/07/2010 to 28/07/2010, Badan Kebajikan Psikiatri Hospital Kuala Lumpur (National)
  • Managing Metabolic Syndrome in Schizophrenia, 12th Congress of ASEAN Federation for Psychiatry and Mental Health, 24/06/2010 to 26/06/2010, ASEAN Federation for Psychiatry and Mental Health (International)
  • Methamphetamine psychosis, Seminar: Substance Abuse Perils, 25/04/2010 to 25/04/2010, Malaysian Medical Association (National)
  • FDA inspection in Malaysia, US FDA Inspection: Experience Sharing Seminar, 24/11/2009 to 24/11/2009, Quintiles (International)
  • Management of schizophrenia, Workshop: Management of Psychosis, 28/10/2009 to 28/10/2009, Hospital Sultanah Bahiyah (National)
  • Remission in depression, 3rd Sarawak Mental Health Conference, 06/08/2009 to 08/08/2009, Hospital Sentosa Kuching (National)
  • Paradigm shift in treatment goals for Depression and Anxiety , 4th Sabah MEntal Health Conference, 22/05/2008 to 24/05/2008, Hospital Mesra Bukit Padang (National)
  • Atypical antipsychotic usage in Malaysia. , Collegium International Neuropsychopharmacology (CINP) Regional Conference, 02/03/2008 to 05/03/2008, Collegium International Neuropsychopharmacology  (International)
  • Psychiatric posting in final year medical students: do attitudes change? , World Psychiatric Association Regional Meeting., 18/04/2007 to 21/04/2007, World Psychiatric Association  (International)
  • Safety and efficacy of rapid dose administration of quetiapine in bipolar mania. , ISS Investigators Meeting, 29/11/2006 to 01/12/2006, Astra Zeneca (International)
    • POSTER PRESENTER
  • Prevalence of psychiatric co-morbidity and suicidality among methamphetamine dependence patients., 11th European Collegium Neuropsychopharmacology (ECNP) Regional Meeting , 14/04/2011 to 16/04/2011, European Collegium Neuropsychopharmacology (ECNP) (International)
  • Aripirazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 12/03/2011 to 15/03/2011, European Psychiatry Association (International)
  • The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry. , 10/09/2005 to 15/09/2005, World Psychiatry Association (International)
    • PRESENTER
  • Identifying and treating depression: Are you at risk? , Syarahan Perdana, 20/02/2019 to 20/02/2019, Jabatan Perubatan Psikologi & Fakulti Perubatan (University)
  • Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: preliminary results, 19th European Congress of Psychiatry, 01/04/2011
  • Ziprasidone treatment effects on lipids in patients with metabolic risk: preliminary results., 18th European Congress of Psychiatry, 01/04/2010
  • Safety and efficacy of aripiprazole in the treatment of amphetamine and methamphetamine induce psychosis: A preliminary results., 9th World Congress of Biological Psychiatry, 01/04/2009
  • Psychiatric co-morbidity among patients with amphetamine and metamphetamine dependence in Malaysia., 22nd European College of Neuropsychopharmacology Congress, 01/04/2009
  • Service utilization and cost associated with switching to risperidone from previous treatment with typical antipsychotic agents., XXVI Collegium International Neuropsychopharmacology (CINP) Congress, 01/04/2008
  • The use of buprenorphine in the treatment of opiate dependence in Malaysia, XIII World Congress of Psychiatry, 01/04/2005
  • Stigma in Mental Illness: Attitudes of Medical Students Towards Mentally Ill Patient, XII World Congress of Psychiatry, 01/04/2002
  • Study of Post Stroke Depression in University Malaya Medical Centre Kuala Lumpur, 4th Biennial Convention of The ASEAN Neurological Association, 01/04/2001